Biological Characterization and Therapeutics for Subscalp Recurrent in Intracranial Glioblastoma
Sign Up to like & getrecommendations! Published in 2020 at "OncoTargets and therapy"
DOI: 10.2147/ott.s265322
Abstract: Purpose Gliomas are common intracranial tumors, of which 70% are malignant gliomas. Glioblastoma multiforme (GBM) is the most aggressive tumor, and patients with GBM have a median survival time of only 9–12 months; extracranial recurrence… read more here.
Keywords: therapeutics subscalp; glioblastoma; subscalp recurrent; characterization therapeutics ... See more keywords